Chemoinformaics analysis of quercetin-3-o-glucoside-7-o-rhamnoside
| Molecular Weight | 354.311 | nRot | 3 |
| Heavy Atom Molecular Weight | 336.167 | nRig | 17 |
| Exact Molecular Weight | 354.095 | nRing | 3 |
| Solubility: LogS | -3.457 | nHRing | 2 |
| Solubility: LogP | 2.488 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 1 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 11 |
| nHA | 9 | APOL | 45.9403 |
| nHD | 5 | BPOL | 24.1337 |
| QED | 0.301 |
| Synth | 3.189 |
| Natural Product Likeliness | 1.714 |
| NR-PPAR-gamma | 0.934 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.008 |
| Pgp-sub | 0.017 |
| HIA | 0.054 |
| CACO-2 | -5.871 |
| MDCK | 0.00000569 |
| BBB | 0.01 |
| PPB | 0.922022 |
| VDSS | 0.649 |
| FU | 0.086922 |
| CYP1A2-inh | 0.495 |
| CYP1A2-sub | 0.128 |
| CYP2c19-inh | 0.022 |
| CYP2c19-sub | 0.042 |
| CYP2c9-inh | 0.158 |
| CYP2c9-sub | 0.298 |
| CYP2d6-inh | 0.029 |
| CYP2d6-sub | 0.204 |
| CYP3a4-inh | 0.089 |
| CYP3a4-sub | 0.037 |
| CL | 14.752 |
| T12 | 0.937 |
| hERG | 0.153 |
| Ames | 0.432 |
| ROA | 0.033 |
| SkinSen | 0.954 |
| Carcinogencity | 0.04 |
| EI | 0.94 |
| Respiratory | 0.124 |
| NR-Aromatase | 0.914 |
| Antiviral | Yes |
| Prediction | 0.684034 |